NEWS

Siyah bir zemin üzerinde, hücre patlamasını andıran, sayısız küçük parçacık içeren parlak kırmızı ve pembe bir küre tasvir edilmiştir.

NEOPRISM-CRC trial shows durable response in 32 patients after immunotherapy

In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab before surgery. This short course of treatment offered remarkably durable protection for some patients.

This is a news summary compiled for the İyi Giden Şeyler newsletter — not the original article. The original article is at sciencedaily.com.

Read the original article English (automatic translation)

Back to the issue